Mostrar el registro sencillo del ítem

Molecular insights into the OGG1 gene, a cancer risk modifier in BRCA1 and BRCA2 mutations carriers

dc.contributor.authorBenitez-Buelga, Carlos
dc.contributor.authorVaclová, Teresa
dc.contributor.authorFerreira, Sofía
dc.contributor.authorUrioste, Miguel
dc.contributor.authorInglada-Pérez, Lucía
dc.contributor.authorSoberón Maltos, Nora Elsa 
dc.contributor.authorBlasco Marhuenda, María Antonia
dc.contributor.authorOsorio, Ana
dc.contributor.authorBenitez, Javier
dc.date.accessioned2017-03-29T05:59:39Z
dc.date.available2017-03-29T05:59:39Z
dc.date.issued2016
dc.identifier.citationOncotarget, 7, 18, p. 25815-25825 (2016); doi:10.18632/oncotarget.8272
dc.identifier.issn1949-2553
dc.identifier.urihttp://hdl.handle.net/10651/41398
dc.description.sponsorshipThe Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health. Additional funds were provided by the NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. Donors were enrolled at Biospecimen Source Sites funded by NCI\SAIC-Frederick, Inc. (SAIC-F) subcontracts to the National Disease Research Interchange (10XS170), Roswell Park Cancer Institute (10XS171), and Science Care, Inc. (X10S172). The Laboratory, Data Analysis, and Coordinating Center (LDACC) was funded through a contract (HHSN268201000029C) to The Broad Institute, Inc. Biorepository operations were funded through an SAIC-F subcontract to Van Andel Institute (10ST1035). Additional data repository and project management were provided by SAIC-F (HHSN261200800001E). The Brain Bank was supported by a supplements to University of Miami grants DA006227 and DA033684 and to contract N01MH000028. Statistical Methods development grants were made to the University of Geneva (MH090941 & MH101814), the University of Chicago (MH090951, MH090937, MH101820, MH101825), the University of North Carolina-Chapel Hill (MH090936 & MH101819), Harvard University (MH090948), Stanford University (MH101782), Washington University St Louis (MH101810), and the University of Pennsylvania (MH101822). The data used for the analyses described in this manuscript were obtained from: [insert, where appropriate] the GTEx Portal on 01/12/2015 and/or dbGaP accession number phs000424.vN.
dc.description.sponsorshipJ.B.'s laboratory is partially funded by the Spanish Ministry of Health PI12/00070 supported by FEDER funds, and the Spanish Research Network on Rare diseases (CIBERER). C.B-B is granted by the PI12/00070. M.A.B.'s laboratory is funded with the Spanish Ministry of Science and Innovation, projects SAF2008-05384 and 2007-A-200950 (TELOMARKER), European Research Council Advanced grant GA#232854, the Körber Foundation, Fundación Botín and Fundación Lilly. MU is supported by the Spanish Ministry of Health PI14/00459 with FEDER funds.
dc.format.extentp. 25815-25825
dc.language.isoeng
dc.publisherImpact Journals LLC
dc.relation.ispartofOncotarget
dc.rightsCC Reconocimiento 3.0
dc.rights© The authors
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84967138138&doi=10.18632%2foncotarget.8272&partnerID=40&md5=efdb776d26cf07572cb5698ce40cff1a
dc.titleMolecular insights into the OGG1 gene, a cancer risk modifier in BRCA1 and BRCA2 mutations carriers
dc.typejournal article
dc.identifier.doi10.18632/oncotarget.8272
dc.relation.projectIDFEDER/PI12/00070
dc.relation.projectIDSAF/2008-05384
dc.relation.projectIDSAF/2007-A-200950
dc.relation.projectIDFEDER/PI14/00459
dc.relation.publisherversionhttp://dx.doi.org/10.18632/oncotarget.8272
dc.rights.accessRightsopen access


Ficheros en el ítem

untranslated

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

CC Reconocimiento 3.0
Este ítem está sujeto a una licencia Creative Commons